Cure My Disease

Don't miss your cure!

 Log in / Sign up

A nurse coordinator might be the key to better Parkinson's care

NCT ID NCT05273957

Disease control Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 31, 2026 · Last updated Sep 01, 2026 · Updated 1 time

Summary

This trial tests whether having a nurse specialist coordinate care for people with Parkinson's or related conditions improves their quality of life over 12 months. Participants are randomly assigned to either standard care with their neurologist or additional support from a nurse case manager who works with a multidisciplinary team. Researchers will measure quality of life, motor and non-motor symptoms, and unscheduled hospital visits to see if the coordinated approach makes a difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A nurse specialist (case manager) who coordinates care between the neurologist and a multidisciplinary team, compared with standard neurologist-only care.
What this could lead to
If it works, this care model could become a standard way to improve quality of life and reduce hospital visits for people with Parkinson's and related conditions.
What could go wrong
This is a relatively small trial, and the benefit may be modest or not apply to all patients. The intervention is organizational, so results depend on how consistently the care model is delivered.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

121 people

The number who actually took part.

Started

Mar 2021

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years * Living in the Lombardy region (Northern Italy) * Duration of Parkinson's disease, atypical or secondary parkinsonism ≥ 3 years * Presence of at least (i) n=1 motor complication and/or (ii), n=2 non-motor symptoms, defined as follows: (i) Motor complication: * Motor fluctuations * ≥ 2 Falls in the last 6 months * Dysphagia (ii) Non Motor symptoms * Non-motor fluctuations * ≥ 2 items of the non-motor symptoms scale with a score ≥ 2 Exclusion Criteria: * Hoehn and Yahr Stage = 5 in the ON-medication condition * Psychiatric comorbidity or other neurological chronic diseases that, in the opinion of the recruiting neurologist, could compromise the study participation. * Patients on infusional therapies (continuous infusion of levodopa-carbidopa intestinal gel or Continuous Subcutaneous Apomorphine Infusion). * Severe medical disease (liver or kidney failure, decompensated heart disease, neoplasms, coagulopathy)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Atypical parkinsonism are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parkinson disease parkinsonian disorder secondary Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Atypical parkinsonism Nurse physician relations Nurse-patient relations Parkinson disease Secondary parkinsonism

Contacts and locations

Locations

  • Azienda Socio-Sanitaria Territoriale Nord Milano

    Sesto San Giovanni, Milan, 20099, Italy

  • Fondazione IRCCS Istituto Neurologico Carlo Besta

    Milan, 20133, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.